Kennondale Capital Management LLC Aldeyra Therapeutics, Inc. Transaction History
Kennondale Capital Management LLC
- $91.7 Billion
- Q1 2025
A detailed history of Kennondale Capital Management LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Kennondale Capital Management LLC holds 151,280 shares of ALDX stock, worth $311,636. This represents 0.95% of its overall portfolio holdings.
Number of Shares
151,280
Previous 151,280
-0.0%
Holding current value
$311,636
Previous $755 Million
15.23%
% of portfolio
0.95%
Previous 0.82%
Shares
1 transactions
Others Institutions Holding ALDX
# of Institutions
135Shares Held
37.6MCall Options Held
814KPut Options Held
537K-
Perceptive Advisors LLC New York, NY9.28MShares$19.1 Million1.54% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.48MShares$11.3 Million17.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.72MShares$7.66 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$7.46 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT1.75MShares$3.61 Million2.26% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $120M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...